+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Leuprorelin Acetate"

Leuprorelin Drugs Market Report 2025 - Product Thumbnail Image

Leuprorelin Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Prostate Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Prostate Cancer Treatment Drugs Markets in China

  • Report
  • August 2024
  • 244 Pages
  • China
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Leuprorelin Acetate is a synthetic hormone used in the treatment of prostate and breast cancer. It is a gonadotropin-releasing hormone agonist (GnRH agonist) that works by blocking the production of testosterone and estrogen, which can slow the growth of certain types of cancer. It is administered as an injection or implant and is often used in combination with other cancer treatments such as chemotherapy and radiation therapy. Leuprorelin Acetate is a widely used drug in oncology, with a range of applications in the treatment of prostate and breast cancer. It is also used to treat endometriosis, uterine fibroids, and precocious puberty. The market for Leuprorelin Acetate is highly competitive, with a number of major pharmaceutical companies offering the drug. These include Pfizer, Novartis, Sanofi, and Takeda. Show Less Read more